Study to Evaluate the Long Term Safety and Efficacy of DWP16001 Compared to Placebo in the Treatment of T2DM.

Clinical trial NCT05376930 · COMPLETED

Trial details

NCT number: NCT05376930
Sponsor: Daewoong Pharmaceutical Co. LTD.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

T2DM (Type 2 Diabetes Mellitus)

Start date: 2021-09-16
Primary completion: 2022-05-31
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.